Newsroom Inflammatix in the news Inflammatix scores BARDA contract for infection tests Nov 14, 2019 How $6 million could help a small Peninsula company spot deadly infections Nov 14, 2019 Inflammatix Inks BARDA Contract for up to $72M Nov 14, 2019 AACC panel votes Inflammatix technology most disruptive Sep 20, 2019 Inflammatix Preps Immune-Response Sepsis Dx for FDA Clinical Trial, Lays Out Future Test Plans Aug 16, 2019 AACC: Inflammatix sepsis test wins Disruptive Technology contest Aug 6, 2019 Novel Technologies, Machine Learning Are The Keys To Improving Acute Infection Diagnostics Feb 13, 2019 Immune Profiling: A New Way to Diagnose Infections Oct 28, 2018 The quest to solve sepsis Apr 17, 2018 Inflammatix: a 2018 World Changing Ideas Award Finalist! Apr 9, 2018 Read Immune Responses to See Infections Mar 15, 2018 Inflammatix announced findings from a new study published in Nature Communications Feb 28, 2018 Older NewsRecent News Inflammatix sepsis test scores FDA breakthrough device designation Nov 28, 2023 Inflammatix Aims for 2024 Launch of 30-Minute Sepsis and Acute Infection Test Nov 28, 2023 Your medical devices are getting smarter. Can the FDA keep them safe? Oct 9, 2023 Older NewsRecent News A Bright Future Ahead for Novel Markers of Infection Dec 15, 2020 Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test Oct 29, 2020 Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform Oct 8, 2020 Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk Sep 30, 2020 Three Predictions For Healthcare Platforms Sep 8, 2020 20 medical device startups you need to know Jun 26, 2020 Older NewsRecent News Press releases Mar 18, 2020 Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force Mar 4, 2020 New Inflammatix Study in Nature Communications Outlines Breakthrough in Diagnosing Acute Infections by Reading the Immune System Jan 10, 2020 Inflammatix Announces $32 Million in Series C Funding Nov 14, 2019 Inflammatix Announces Funding from BARDA to Advance HostDx™ Tests Aug 6, 2019 Inflammatix Wins AACC’s Disruptive Technology Award For Its Rapid HostDx™ Tests May 16, 2019 Inflammatix Named a Finalist for AACC’s Disruptive Technology Award for Its Rapid HostDx™ Tests Older Press ReleasesRecent Press Releases Machine learning blogs Podcasts Diagnosing Infection with Ljubomir Buturovic from Inflammatix December 2023 Advances in Sepsis Diagnostics: the HostDx Sepsis Platform May 2018 Media Contact [email protected]
Inflammatix Preps Immune-Response Sepsis Dx for FDA Clinical Trial, Lays Out Future Test Plans Aug 16, 2019
Novel Technologies, Machine Learning Are The Keys To Improving Acute Infection Diagnostics Feb 13, 2019
Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test Oct 29, 2020
Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform Oct 8, 2020
Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk Sep 30, 2020
Mar 4, 2020 New Inflammatix Study in Nature Communications Outlines Breakthrough in Diagnosing Acute Infections by Reading the Immune System
May 16, 2019 Inflammatix Named a Finalist for AACC’s Disruptive Technology Award for Its Rapid HostDx™ Tests
